The Department of Defense (DOD) is launching its first-ever clinical trial of MDMA-assisted therapy for active-duty service members with PTSD at Walter Reed National Military Medical Center. In our latest Pα+ interview, Psychedelic Alpha Editor Josh Hardman speaks with Aaron Wolfgang, Chief of Inpatient Psychiatry at the US Army, for a first look at the study’s design. The landmark trial…

Source

Previous articleOpinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics
Next articleUK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in Parliamentary Report